Amphastar Pharmaceuticals (AMPH) Other financing activities (2013 - 2025)

Amphastar Pharmaceuticals has reported Other financing activities for 12 years, with the latest figure at $2.0 million in Q4 2025.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $2.0 million in Q4 2025; TTM through Dec 2025 was $8.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.9 million, changed N/A from the prior year.
• Other financing activities was $2.0 million for Q4 2025 at Amphastar Pharmaceuticals, up from $379000.0 in the prior quarter.
• The five-year high for Other financing activities was $5.7 million in Q4 2021, with the low at $379000.0 in Q3 2025.
• Average Other financing activities over 4 years is $2.6 million, with a median of $2.1 million recorded in 2022.
• The sharpest annual moves came in 2021 and 2022: Other financing activities surged 205.5% in 2021, then sank 64.0% in 2022.
• Over 4 years, Other financing activities stood at $5.7 million in 2021, then tumbled by 64.0% to $2.0 million in 2022, then soared by 74.68% to $3.6 million in 2023, then plunged by 44.33% to $2.0 million in 2025.
• The last three Other financing activities figures came in at $2.0 million (Q4 2025), $379000.0 (Q3 2025), and $3.6 million (Q4 2023), per Business Quant data.